Does Hemab Therapeutics Holdings (COAG) Pay a Dividend? (2026)
Last updated July 2026
Short answer
Hemab Therapeutics Holdings (COAG) pays little or no dividend; like many growth-oriented companies it reinvests cash rather than paying income. A dividend is a slice of profits returned to shareholders, and the yield is that payout divided by the share price, so it drifts as both change. Figures here are approximate; verify the current number with your broker.
Does Hemab Therapeutics Holdings (COAG) pay a dividend?
Hemab Therapeutics Holdings (COAG) currently returns little or nothing as a dividend. COAG has no meaningful product revenue and is valued on the expected future worth of its pipeline, not on earnings, so standard metrics like P/E do not apply. Its roughly $2.3 billion market cap sits against ongoing net losses of about $71 million, offset by a strong cash position funding operations into 2029. The stock has risen from an $18 IPO price toward $49, meaning the market already prices in meaningful clinical success.
How to think about COAG's dividend
- Yield is a snapshot: minimal today, but it moves with price and payout.
- Total return vs income: dividends are one part of return; price change is usually the bigger part for a name like COAG.
- Reinvest or take income: a DRIP compounds; taking the cash gives income now.
- For more yield: dedicated dividend stocks and ETFs target higher payouts. See the best dividend ETFs.
The bottom line on the COAG dividend
Hemab Therapeutics Holdings (COAG) is not an income stock; if you own it, it is for growth or total return, not the dividend. For the full picture see the COAG guide. Walnut can show how COAG fits your real portfolio. It is not an investment adviser.
Build a basket around COAG with Walnut
Use Hemab Therapeutics Holdings as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
Does Hemab Therapeutics Holdings (COAG) pay a dividend?
+
Hemab Therapeutics Holdings (COAG) pays little or no dividend; like many growth-stage companies it tends to reinvest cash rather than return it as income. Verify the current policy on COAG's investor relations page.
What is COAG's dividend yield?
+
COAG's yield is minimal or zero. Companies prioritizing growth often pay no dividend and return cash through buybacks instead, if at all.
How often does COAG pay its dividend?
+
US companies that pay dividends, like Hemab Therapeutics Holdings if it does, typically distribute them quarterly. Confirm the exact schedule and ex-dividend dates on COAG's investor relations page before relying on the timing.
Can I reinvest COAG dividends?
+
Yes. Most brokers offer automatic dividend reinvestment (a DRIP) so any COAG dividend buys more shares automatically. It compounds over time but is still taxable in a taxable account.
Is COAG a good dividend stock?
+
Walnut is informational, not investment advice. COAG is a growth or total-return name rather than an income stock. Dedicated dividend stocks and ETFs target higher, steadier yield; match the choice to whether you want income now or growth.
Does COAG pay a dividend?
+
No. Hemab does not pay a dividend and, like most clinical-stage biotechs, reinvests all capital into research and development rather than returning cash to shareholders.
Walnut is informational, not investment advice. Dividend figures are approximate and dated; verify current yield, schedule, and policy with COAG's investor relations page or your broker.